RANKL inhibition: a new target of treating diabetes mellitus?Baodi Xing, Yuxiu Li|Therapeutic Advances in Endocrinology and Metabolism|2023Cited by 22
Insulin and liraglutide attenuate brain pathology in diabetic mice by enhancing the Wnt/β‑catenin signaling pathwayYuan Zhao, Yuxiu Li|Experimental and Therapeutic Medicine|2022Cited by 12
Ling-gui-zhu-gan granules reduces obesity and ameliorates metabolic disorders by inducing white adipose tissue browning in obese miceYuxiu Li, Rui Wu|Frontiers in Physiology|2024Cited by 2